| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner
1 company
Lustig Marc is a Director, 10% Owner at BriaCell Therapeutics Corp.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $10.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 14, 2024 | BCTX Briacell Therapeutics Corp. | Director, 10% Owner | Buy | 902,935 | $2.22 | $2,000,001.03 | +55.1% |